Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients
Labcorp Holdings Inc. (LH)
Last labcorp holdings inc. earnings: 4/29 06:53 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=84636&p=irol-irhome
Company Research
Source: PR Newswire
Research to be presented in a joint poster session with Labcorp at the 2024 San Antonio Breast Cancer SymposiumBOSTON and BURLINGTON, N.C., Nov. 26, 2024 /PRNewswire/ -- Outcomes4Me Inc., the developer of the first and only end-to-end, actionable cancer platform, announced today it has been selected to present the results of a biomarker awareness study, conducted with Labcorp, a global leader of innovative and comprehensive laboratory services, at the prestigious 2024 San Antonio Breast Cancer Symposium (SABCS) on December 13, 2024. SABCS is the preeminent conference for sharing cutting-edge breast cancer research with healthcare professionals, researchers, and patient advocates worldwide."Following the results of the DESTINY-BREAST04 trial at the American Society of Clinical Oncology meeting in 2022, HER2-low emerged as an important biomarker within metastatic breast cancer (mBC)," said Maya R. Said, Sc.D., Founder and CEO of Outcomes4Me. "We knew that many patients living with mBC w
Show less
Read more
Impact Snapshot
Event Time:
LH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LH alerts
High impacting Labcorp Holdings Inc. news events
Weekly update
A roundup of the hottest topics
LH
News
- Labcorp Launches H5 Bird Flu Test Amid US Outbreak: Stock to Gain? [Yahoo! Finance]Yahoo! Finance
- Laboratory Co. of America Holdings (NYSE: LH) had its price target raised by analysts at Morgan Stanley from $260.00 to $270.00. They now have an "overweight" rating on the stock.MarketBeat
- LH Stock May Gain From Select MAWD Pathology Asset Purchase Deal [Yahoo! Finance]Yahoo! Finance
- Lip Injection Market to hit USD 5.95 billion by 2032, says Global Market Insights Inc. [Yahoo! Finance]Yahoo! Finance
- Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians [Yahoo! Finance]Yahoo! Finance
LH
Earnings
- 10/24/24 - Beat
LH
Sec Filings
- 12/4/24 - Form 4
- 12/4/24 - Form 4
- 12/4/24 - Form 4
- LH's page on the SEC website